These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 20148470)
1. Primary peritoneal spindle cell sarcoma presented with massive ascites: a case report. Bilici A; Uygun K; Altun E; Karci E; Gurbuz Y; Semih Dogan A J BUON; 2009; 14(4):721-3. PubMed ID: 20148470 [TBL] [Abstract][Full Text] [Related]
2. Treatment results obtained in metastatic soft-tissue sarcoma with a combination of doxorubicin and dacarbazine or doxorubicin and ifosfamide. Weh HJ; Agarwal K; Zornig C; Schwarz R; Dietel M; Hossfeld DK Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S189-93. PubMed ID: 8453696 [TBL] [Abstract][Full Text] [Related]
3. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study. Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644 [TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy for pulmonary metastases of soft tissue sarcoma]. Kito M; Umeda T Gan To Kagaku Ryoho; 1998 Sep; 25(11):1701-6. PubMed ID: 9757195 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas. Maurel J; López-Pousa A; de Las Peñas R; Fra J; Martín J; Cruz J; Casado A; Poveda A; Martínez-Trufero J; Balañá C; Gómez MA; Cubedo R; Gallego O; Rubio-Viqueira B; Rubió J; Andrés R; Sevilla I; de la Cruz JJ; Del Muro XG; Buesa JM J Clin Oncol; 2009 Apr; 27(11):1893-8. PubMed ID: 19273704 [TBL] [Abstract][Full Text] [Related]
6. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study. Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY; J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494 [TBL] [Abstract][Full Text] [Related]
7. The management of patients with uterine sarcoma: a debated clinical challenge. Gadducci A; Cosio S; Romanini A; Genazzani AR Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430 [TBL] [Abstract][Full Text] [Related]
8. The role of ifosfamide in the treatment of sarcomas. Dirix LY; Van Oosterom AT Semin Oncol; 1989 Feb; 16(1 Suppl 3):39-45. PubMed ID: 2649984 [TBL] [Abstract][Full Text] [Related]
9. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review. Dirix LY; Van Oosterom AT Semin Oncol; 1990 Apr; 17(2 Suppl 4):50-7. PubMed ID: 2185547 [TBL] [Abstract][Full Text] [Related]
10. Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic. Demetri GD; Elias AD Hematol Oncol Clin North Am; 1995 Aug; 9(4):765-85. PubMed ID: 7490240 [TBL] [Abstract][Full Text] [Related]
11. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS). Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM; Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685 [TBL] [Abstract][Full Text] [Related]
12. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472 [TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of advanced bone and soft tissue sarcoma]. Yamawaki S; Isu K; Ubayama Y; Yamaguti H; Gotou M Gan To Kagaku Ryoho; 1984 Sep; 11(9):1757-63. PubMed ID: 6541020 [TBL] [Abstract][Full Text] [Related]
14. Preoperative doxorubicin plus ifosfamide in primary soft-tissue sarcomas of the extremities. Azzarelli A; Quagliuolo V; Casali P; Fissi S; Montalto F; Santoro A Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S210-2. PubMed ID: 8453700 [TBL] [Abstract][Full Text] [Related]
15. [Soft tissue sarcoma: postoperative chemotherapy]. Goto T; Kosaku H; Kobayashi H; Hozumi T; Kondo T Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of ifosfamide in combination with doxorubicin for the treatment of metastatic soft-tissue sarcoma. The Eastern Cooperative Oncology Group. Blum RH; Edmonson J; Ryan L; Pelletier L Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S238-40. PubMed ID: 8453706 [TBL] [Abstract][Full Text] [Related]
17. The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma Group. Steward WP; Verweij J; Somers R; Spooner D; Kerbrat P; Clavel M; Crowther D; Rouesse J; Tursz T; Tueni E Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S241-4. PubMed ID: 8453707 [TBL] [Abstract][Full Text] [Related]
18. Ifosfamide combination regimens for soft-tissue sarcoma. Stuart-Harris R; Dalley D; Bell DR; Levi J; Simes RJ; Wiltshaw E Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S185-8. PubMed ID: 8453695 [TBL] [Abstract][Full Text] [Related]
19. [Value of neoadjuvant radiochemotherapy in undifferentiated soft tissue sarcomas]. Stuschke M Strahlenther Onkol; 1994 Aug; 170(8):480-3. PubMed ID: 8085215 [No Abstract] [Full Text] [Related]
20. A rare cause of abdominal pain and ascites. Thackeray EW; Sukov WR; Sweetser S Gastroenterology; 2012 Dec; 143(6):e5-6. PubMed ID: 23089547 [No Abstract] [Full Text] [Related] [Next] [New Search]